- Home
- VKTX vs CDP Comparison
VKTX vs CDP Comparison
Compare VKTX & CDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- CDP
- Stock Information
- Founded
- VKTX 2012
- CDP 1988
- Country
- VKTX United States
- CDP United States
- Employees
- VKTX N/A
- CDP N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- CDP Real Estate Investment Trusts
- Sector
- VKTX Health Care
- CDP Real Estate
- Exchange
- VKTX Nasdaq
- CDP Nasdaq
- Market Cap
- VKTX 3.5B
- CDP 3.1B
- IPO Year
- VKTX 2015
- CDP N/A
- Fundamental
- Price
- VKTX $26.98
- CDP $30.64
- Analyst Decision
- VKTX Strong Buy
- CDP Strong Buy
- Analyst Count
- VKTX 13
- CDP 5
- Target Price
- VKTX $86.92
- CDP $33.60
- AVG Volume (30 Days)
- VKTX 9.7M
- CDP 990.7K
- Earning Date
- VKTX 10-22-2025
- CDP 10-27-2025
- Dividend Yield
- VKTX N/A
- CDP 4.01%
- EPS Growth
- VKTX N/A
- CDP N/A
- EPS
- VKTX N/A
- CDP 1.27
- Revenue
- VKTX N/A
- CDP $751,457,000.00
- Revenue This Year
- VKTX N/A
- CDP N/A
- Revenue Next Year
- VKTX N/A
- CDP $4.56
- P/E Ratio
- VKTX N/A
- CDP $23.91
- Revenue Growth
- VKTX N/A
- CDP 3.13
- 52 Week Low
- VKTX $18.92
- CDP $23.92
- 52 Week High
- VKTX $81.73
- CDP $34.22
- Technical
- Relative Strength Index (RSI)
- VKTX 41.03
- CDP 75.66
- Support Level
- VKTX $26.13
- CDP $28.30
- Resistance Level
- VKTX $28.26
- CDP $29.08
- Average True Range (ATR)
- VKTX 1.63
- CDP 0.53
- MACD
- VKTX -0.39
- CDP 0.24
- Stochastic Oscillator
- VKTX 19.82
- CDP 96.58
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About CDP COPT Defense Properties of Beneficial Interest
COPT Defense Properties is a fully-integrated and self-managed real estate investment trust (REIT) focused on owning, operating and developing properties in locations proximate to, or sometimes containing, key U.S. Government (USG) defense installations and missions. Its tenants include the USG and their defense contractors, who are engaged in priority national security activities, and who generally require mission-critical and high security property enhancements. Its properties include 195 operating properties totaling approximately 22.4 million square feet comprised of 16.5 million square feet in 164 office properties and 5.9 million square feet in 31 single-tenant data center shells.